ArticleRevista peruana de medicina experimental y salud publica2025
Years of potential life lost due to drug-susceptible pulmonary tuberculosis in Cali, Colombia, 2009-2020.
Article in Revista peruana de medicina experimental y salud publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A cross-sectional descriptive and analytical study evaluated years of potential life lost (YPLL) due to drug-susceptible pulmonary tuberculosis in Cali from 2009 to 2020, using death records from the Health Secretariat. Total YPLL and its annual rate were calculated by age at death, and median YPLL values were compared across subgroups. A total of 565 registers of death records were analyzed (71.5% men; median age 56 years, range 38-70), yielding 11,238 YPLL. The highest median YPLL were observed among persons living with HIV, those in socially vulnerable situations, the uninsured or those under subsidized or special coverage, in women, and in those who re-entered after previously discontinuing treatment or experiencing a tuberculosis relapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.